Remepy is Pioneering Hybrid Drugs™. 
We believe that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs™. These will include both a software component and a traditional drug component - influencing patients via Hybrid Mechanisms of Action™.

Remepy’s Digital Molecules™ are designed to be the software components within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug. 
The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. 

Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine  Remepy’s Digital Molecule™ and traditional drug components.

Pharmaceutical

Remepy

Remepy's headquarters in Ramat Gan, Israel

Or Shoval

Hagar Tamir

Guy Shalom

Nora Siperman

Sheila Oren

Shai Elrich

Shahar Shelly

Nira Saporta

Amir Amedi

Leadership Team

Medical and Clinical Team

Engineering Team

Remepy

Org chart

Teams

Leadership Team

Medical and Clinical Team

Engineering Team

Offices

Similar companies